Unlock stock picks and a broker-level newsfeed that powers Wall Street.
0.3725
-0.0345
(-8.48%)
At close: April 1 at 4:00:00 PM EDT
0.3844
+0.01
+(3.19%)
After hours: April 1 at 7:55:15 PM EDT
Research Analysis
Earnings Estimate
| Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| No. of Analysts | 1 | 1 | 2 | 2 |
| Avg. Estimate | -0.07 | -0.08 | -0.34 | -0.39 |
| Low Estimate | -0.07 | -0.08 | -0.4 | -0.5 |
| High Estimate | -0.07 | -0.08 | -0.27 | -0.28 |
| Year Ago EPS | -0.14 | -0.09 | -0.33 | -0.34 |
Revenue Estimate
| Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| No. of Analysts | 1 | 1 | 3 | 3 |
| Avg. Estimate | -- | -- | 8.9M | 8.97M |
| Low Estimate | -- | -- | -- | -- |
| High Estimate | -- | -- | 16.5M | 19.2M |
| Year Ago Sales | 2.18M | 6.4M | 28.7M | 8.9M |
| Sales Growth (year/est) | -100.00% | -100.00% | -68.99% | 0.75% |
Earnings History
| Currency in USD | 3/31/2024 | 6/30/2024 | 9/30/2024 | 12/31/2024 |
|---|---|---|---|---|
| EPS Est. | -0.18 | 0.04 | -0.09 | -0.11 |
| EPS Actual | -0.14 | -0.09 | -0.06 | -0.05 |
| Difference | 0.04 | -0.13 | 0.03 | 0.06 |
| Surprise % | 22.22% | -325.00% | 29.41% | 54.55% |
EPS Trend
| Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| Current Estimate | -0.07 | -0.08 | -0.34 | -0.39 |
| 7 Days Ago | -0.12 | -0.12 | -0.41 | -0.49 |
| 30 Days Ago | -0.12 | -0.12 | -0.41 | -0.49 |
| 60 Days Ago | -0.12 | -0.12 | -0.41 | -0.49 |
| 90 Days Ago | -0.12 | -0.12 | -0.41 | -0.49 |
EPS Revisions
| Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| Up Last 7 Days | 1 | -- | 1 | 1 |
| Up Last 30 Days | -- | -- | 1 | 1 |
| Down Last 7 Days | -- | -- | -- | -- |
| Down Last 30 Days | -- | -- | -- | -- |
Growth Estimates
| Current Qtr. | Next Qtr. | Current Year | Next Year | |
|---|---|---|---|---|
| VXRT | 50.00% | 11.11% | -1.52% | -16.42% |
| S&P 500 | 6.69% | 6.80% | 9.98% | 14.34% |
Upgrades & Downgrades
| Maintains | B. Riley Securities: Buy to Buy | 3/27/2025 |
| Initiated | Oppenheimer: Outperform | 8/15/2024 |
| Upgrade | B. Riley Securities: Neutral to Buy | 1/31/2024 |
| Reiterates | Cantor Fitzgerald: Overweight to Overweight | 9/7/2023 |
| Maintains | Cantor Fitzgerald: Overweight to Overweight | 8/7/2023 |
| Maintains | B. Riley Securities: Neutral | 12/19/2022 |
Related Tickers
INO Inovio Pharmaceuticals, Inc.
1.5000
-7.98%
OCGN Ocugen, Inc.
0.6472
-8.37%
NVAX Novavax, Inc.
6.00
-6.40%
IBIO iBio, Inc. Common Stock
3.9100
-2.74%
SRNE Sorrento Therapeutics, Inc.
0.0010
0.00%
JAGX Jaguar Health, Inc.
4.7600
+0.21%
TNXP Tonix Pharmaceuticals Holding Corp.
17.45
-2.38%
CVAC CureVac N.V.
2.7200
-1.81%
ALT Altimmune, Inc.
4.7450
-5.10%
VIR Vir Biotechnology, Inc.
6.18
-4.63%